PLRX Q3 2020 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$82M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M

Gross Profit

$5M100.0% margin

Operating Income

-$17M-346.1% margin

Net Income

-$17M-343.5% margin

EPS (Diluted)

$-0.47

QoQ Revenue Growth

+33.7%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$312M

Total Liabilities

$12M

Stockholders' Equity

$300M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$0	—
Gross Profit	$5M	$0	—
Operating Income	-$17M	-$13M	-24.7%
Net Income	-$17M	-$13M	-24.7%